NCT03173625View on ClinicalTrials.gov

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

April 15, 2017

Study Completion Date

April 15, 2017

Conditions
Healthy Subjects
Interventions
DRUG

AC-076 for s.c. administration

Lyophilized AC-076A to be reconstituted with 1 mL of water for injection

DRUG

Placebo

Sterile 0.9% w/v sodium chloride solution

Trial Locations (1)

07103

Biotrial Inc., Newark

All Listed Sponsors
lead

Viatris Innovation GmbH

INDUSTRY

NCT03173625 - A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body | Biotech Hunter | Biotech Hunter